<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a 43-year-old man with <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> and pulmonary <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The initial treatment with <z:chebi fb="5" ids="28304">heparin</z:chebi> was unsuccessful </plain></SENT>
<SENT sid="2" pm="."><plain>The patient's mother died of mesenteric vein <z:mp ids='MP_0005048'>thrombosis</z:mp> and his sister died at the age of 37 of cerebral <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Haemostatis tests revealed <z:mpath ids='MPATH_458'>normal</z:mpath> screening tests of haemostasis, but decreased levels of abouth 50% of the <z:mpath ids='MPATH_458'>normal</z:mpath> level were established by the activity assay and immunological assay of AT III </plain></SENT>
<SENT sid="4" pm="."><plain>The same level of AT III was found in the patients asymptomatic daughter </plain></SENT>
<SENT sid="5" pm="."><plain>The patient was successfully treated with <z:chebi fb="5" ids="28304">heparin</z:chebi> combined with AT III concentrate and oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>On the basis of these laboratory findings and family data we established that the patient and his daughter had type I congenital AT III deficiency </plain></SENT>
</text></document>